Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Azelastine Hydrochloride Eye Drops
- Product Name
- 盐酸氮䓬斯汀滴眼液
- Approval Number
- 国药准字H20249546
- Approval Date
- Dec 1, 2024
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20244569
- Approval Date
- Jul 30, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20234639
- Approval Date
- Dec 13, 2023
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20234470
- Approval Date
- Nov 14, 2023
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20233973
- Approval Date
- Aug 1, 2023
NMPA
Erythromycin Ethylsuccinate Tablets
- Product Name
- 琥乙红霉素片
- Approval Number
- 国药准字H34023527
- Approval Date
- Nov 26, 2020
NMPA
Clindamycin Hydrochloride and Metronidazole Liniment
- Product Name
- 克林霉素甲硝唑搽剂
- Approval Number
- 国药准字H20055176
- Approval Date
- Feb 28, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found